Huizinga EG - Search Results

1

Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.

van Wijk R, Huizinga EG, van Wesel AC, van Oirschot BA, Hadders MA, van Solinge WW. van Wijk R, et al. Among authors: huizinga eg. Hum Mutat. 2009 Mar;30(3):446-53. doi: 10.1002/humu.20915. Hum Mutat. 2009. PMID: 19085939

2

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.

van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, van Solinge WW. van Wijk R, et al. Among authors: huizinga eg. Blood. 2001 Jul 15;98(2):358-67. doi: 10.1182/blood.v98.2.358. Blood. 2001. PMID: 11435304 Free article.

3

Erythrocytosis associated with a novel missense mutation in the HIF2A gene.

van Wijk R, Sutherland S, Van Wesel AC, Huizinga EG, Percy MJ, Bierings M, Lee FS. van Wijk R, et al. Among authors: huizinga eg. Haematologica. 2010 May;95(5):829-32. doi: 10.3324/haematol.2009.017582. Epub 2009 Dec 8. Haematologica. 2010. PMID: 20007141 Free PMC article.

4

HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia.

van Wijk R, Rijksen G, Huizinga EG, Nieuwenhuis HK, van Solinge WW. van Wijk R, et al. Among authors: huizinga eg. Blood. 2003 Jan 1;101(1):345-7. doi: 10.1182/blood-2002-06-1851. Epub 2002 Aug 8. Blood. 2003. PMID: 12393545 Free article.

5

Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase.

van Wijk R, Huizinga EG, Prins I, Kors A, Rijksen G, Bierings M, van Solinge WW. van Wijk R, et al. Among authors: huizinga eg. Blood Cells Mol Dis. 2004 Jan-Feb;32(1):112-7. doi: 10.1016/j.bcmd.2003.10.006. Blood Cells Mol Dis. 2004. PMID: 14757424

6

Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain.

Staelens S, Hadders MA, Vauterin S, Platteau C, De Maeyer M, Vanhoorelbeke K, Huizinga EG, Deckmyn H. Staelens S, et al. Among authors: huizinga eg. J Biol Chem. 2006 Jan 27;281(4):2225-31. doi: 10.1074/jbc.M508191200. Epub 2005 Nov 28. J Biol Chem. 2006. PMID: 16314412 Free article.

7

Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.

van der Plas RM, Gomes L, Marquart JA, Vink T, Meijers JC, de Groot PG, Sixma JJ, Huizinga EG. van der Plas RM, et al. Among authors: huizinga eg. Thromb Haemost. 2000 Dec;84(6):1005-11. Thromb Haemost. 2000. PMID: 11154106

8

Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.

Huizinga EG, Martijn van der Plas R, Kroon J, Sixma JJ, Gros P. Huizinga EG, et al. Structure. 1997 Sep 15;5(9):1147-56. doi: 10.1016/s0969-2126(97)00266-9. Structure. 1997. PMID: 9331419 Free article.

9

Mapping the collagen-binding site in the von Willebrand factor-A3 domain.

Romijn RA, Westein E, Bouma B, Schiphorst ME, Sixma JJ, Lenting PJ, Huizinga EG. Romijn RA, et al. Among authors: huizinga eg. J Biol Chem. 2003 Apr 25;278(17):15035-9. doi: 10.1074/jbc.M208977200. Epub 2003 Feb 11. J Biol Chem. 2003. PMID: 12582178 Free article.

10

Structure of complement component C2A: implications for convertase formation and substrate binding.

Milder FJ, Raaijmakers HC, Vandeputte MD, Schouten A, Huizinga EG, Romijn RA, Hemrika W, Roos A, Daha MR, Gros P. Milder FJ, et al. Among authors: huizinga eg. Structure. 2006 Oct;14(10):1587-97. doi: 10.1016/j.str.2006.08.008. Structure. 2006. PMID: 17027507 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page